China (Mainland)
Crisaborole API & Intermediates CAS NO.906673-24-3
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Product Details
Keywords
- Crisaborole
- 5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole
- Eucrisa
Quick Details
- ProName: Crisaborole API & Intermediates
- CasNo: 906673-24-3
- Molecular Formula: C14H10BNO3
- Application: Crisaborole is a novel oxaborole appro...
- DeliveryTime: In stock
- PackAge: Barrel sealed
- ProductionCapacity: 500 Kilogram/Day
- Purity: ≥99%
- LimitNum: 1 Gram
Superiority
Our company has commercialized this product for long-term stable supply, the purity ≥ 99.5%. At present, our sales of this product have reached more than 670 kg
Details
Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving disease severity, reducing the risk of infection and reducing the signs and symptoms in patients 2 years old and older. It reduces the local inflammation in the skin and prevents further exacerbation of the disease with a good safety profile. Its structure contains a boron atom, which facilitates skin penetration and binding to the bimetal center of the phosphodiesterase 4 enzyme. It is currently under development as topical treatment of psoriasis.
Factory profile：
Located in Changzhi, Shanxi including 2500㎡ analysis laboratories equipped with HPLC, GC and other analytical facilities.
One pilot and two mass production workshop with more than 70 glass lined reactors, total reaction capacity can reach 35000L.
- MOA
- ROS
- COA
- MSDS
- GMP Standard
- ISO9001:2008 Quality System Certification